Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for Dccr (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
soleno therapeutics宣佈向美國FDA提交新的藥物申請，以治療普拉德-威利綜合徵的Dccr（Diazoxide Choline）緩釋片劑。